Caribou Biosciences
(NASDAQ) CRBU
Caribou Biosciences Financials at a Glance
Market Cap
$172.01M
Revenue (TTM)
$11.16M
Net Income (TTM)
$148.13M
EPS (TTM)
$-1.59
P/E Ratio
-1.12
Dividend
$0.00
Beta (Volatility)
0.00 (Low)
Dividend
$0.00
Beta (Volatility)
0.00 (Low)
Price
$1.71
Volume
37,723
Open
$1.79
Price
$1.71
Volume
37,723
Open
$1.79
Previous Close
$1.71
Daily Range
$1.69 - $1.79
52-Week Range
$0.66 - $3.54
Dividend
$0.00
Beta (Volatility)
0.00 (Low)
Price
$1.71
Volume
37,723
Open
$1.79
Previous Close
$1.71
Daily Range
$1.69 - $1.79
52-Week Range
$0.66 - $3.54
CRBU News
CRBU: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Caribou Biosciences
Industry
Biotechnology
Sector
Health CareEmployees
97
CEO
Rachel E. Haurwitz, PhD
Website
www.cariboubio.comHeadquarters
Berkeley, CA 94710, US
CRBU Financials
Key Financial Metrics (TTM)
Gross Margin
88%
Operating Margin
-13%
Net Income Margin
-13%
Return on Equity
-79%
Return on Capital
-96%
Return on Assets
-82%
Earnings Yield
-89.29%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$172.01M
Shares Outstanding
96.64M
Volume
37.72K
Short Interest
0.00%
Avg. Volume
1.22M
Financials (TTM)
Gross Profit
$7.51M
Operating Income
$136.19M
EBITDA
$132.55M
Operating Cash Flow
$110.99M
Capital Expenditure
$1.36M
Free Cash Flow
$112.35M
Cash & ST Invst.
$139.34M
Total Debt
$27.23M
Caribou Biosciences Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$3.94M
+89.7%
Gross Profit
$3.26M
+111.7%
Gross Margin
82.69%
N/A
Market Cap
$172.01M
N/A
Market Cap/Employee
$1.17M
N/A
Employees
147
N/A
Net Income
$26.49M
+25.4%
EBITDA
$27.77M
+25.1%
Quarterly Fundamentals
Net Cash
$112.11M
-38.8%
Accounts Receivable
$2.98M
-8.4%
Inventory
$0.00
N/A
Long Term Debt
$26.03M
+3.9%
Short Term Debt
$1.20M
-15.8%
Return on Assets
-82.46%
N/A
Return on Invested Capital
-96.19%
N/A
Free Cash Flow
$20.61M
+42.7%
Operating Cash Flow
$20.82M
+41.3%